Author

Yukako Akiyama

Tohoku UniversityPrimary ORCID profile (0009-0000-4987-3628 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Yukako AkiyamaiD1 paper · University of California, San Francisco

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Chitose SuzukiiD· 1 shared Eiichi N. KodamaiD· 1 shared Eiji ItoiiD· 1 shared Eikan MishimaiD· 1 shared Hironori HayashiiD· 1 shared Ken‐ichiro HayashiiD· 1 shared Koichi Kikuchi· 1 shared Makoto KanzakiiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Chitose SuzukiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NeurosciencePLoS ONEPeer-reviewedDec 2, 2020

Mitochondrial dysfunction underlying sporadic inclusion body myositis is ameliorated by the mitochondrial homing drug MA-5

Yoshitsugu Oikawa, Rumiko Izumi, Masashi Koide…·Takaaki Abe

This study identifies mitochondrial dysfunction in sporadic inclusion body myositis and shows that MA-5 improves mitochondrial function and protects myoblasts.

37 citations

humanbulk RNA-seq

𝕏 PostBluesky